Abstract
Durable mechanical circulatory support is increasingly being utilised for patients with end-stage heart failure, with good long-term outcomes. However, the options for durable biventricular support remain limited, with the SynCardia total artificial heart being the only world-wide approved device, albeit with well documented limitations. This abstract discusses animal work with two upcoming durable biventricular assist devices.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have